What is Tarceva?

Category: Prescription Drugs

true

Generic name: Erlotinib

Tarceva®, a brand name for erlotinib, can be used to treat locally advanced or metastatic EGFR positive non-small cell lung cancer. It can also be used in combination with gemcitabine as a first-line treatment for locally advanced, unresectable, or metastatic pancreatic cancer.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Adenocarcinoma (non-small cell lung cancer) 28 17
Lung cancer 4 3
Non-small cell lung cancer 4 2
Small cell lung cancer 1 1
Squamous cell carcinoma (non-small cell lung cancer) 1 0
Unclassified carcinoma (non-small cell lung cancer) 1 1

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 5
Moderate 7
Mild 11
None 1

Commonly reported side effects and conditions associated with Tarceva

Side effect Patients
Diarrhea 12
Dry skin 4
Rashes (redness, swelling) 4
Rash or skin problems 4
Fatigue 3
Acne breakout 2

Show all 31 reported side effects

Dosages

Based on patients currently taking Tarceva

Dosage Patients
150 mg daily 8
75 mg daily 2
100 mg daily 2
500 mg weekly 1
100 mg twice daily 1

Why patients stopped taking Tarceva

Multiple reasons could be selected

Reason Patients
Did not seem to work 4
Side effects too severe 2
Doctor's advice 1
Other 1
See all 8 patients who've stopped taking Tarceva

Duration

Currently taking Tarceva

Duration Patients
1 - 6 months 1
6 months - 1 year 2
1 - 2 years 4
2 - 5 years 5
5 - 10 years 1
10 years or more 2

Stopped taking Tarceva

Duration Patients
1 - 6 months 2
6 months - 1 year 2
1 - 2 years 4
Adherence
Adherence Evaluations
Always 21
Usually 0
Sometimes 2
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 8
Not at all hard to take 15
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 3
$50-99 2
$25-49 2
< $25 3
Not specified 13

What people switch to and from

Patients started taking Tarceva after stopping:

Treatment Patients
Afatinib (Gilotrif) 1
Gefitinib (Iressa) 1

Patients stopped taking Tarceva and switched to:

Treatment Patients
Osimertinib (Tagrisso) 3
Gefitinib (Iressa) 2
Afatinib (Gilotrif) 1
Chemotherapy 1
Pembrolizumab (Keytruda) 1
Last updated:
There are no evaluations for Tarceva.